A 24 weeks, randomized, double-blind, placebo-controlled human trial of Allium fistulosum L. root extract on improvement of child height growth
- Conditions
- Not Applicable
- Registration Number
- KCT0005981
- Lead Sponsor
- Daejeon Korean Medicine Hospital of Daejeon University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
1) Children before adolescence, 3~ 25 percentile based on 2017 Korea standard growth chart percentile
2) Spontaneously agreed to participate in the study by the patients and legal guardians or parents
1) Participants who have taken Hormone replacement therapy or calcitonin, Phosphonate, growth hormone within 6 month prior to the screening examination
2) Participants with a clinically significant disease requiring treatment (i.e., acute or chronic cardiovascular system, endocrine system, immune system, respiratory system, kidney and urinary system, neuropsychiatric system, musculoskeletal inflammation, inflammatory disease, blood and tumor disease, gastrointestinal disease, etc.)
3) Participants who take medicine or health functional food for improvement of child height growth within 3 month prior to the screening examination
4) Participants with a history of antipsychotic medication use within 3 months prior to the screening examination
5) Participantts who have participated in other clinical trials within 3 months prior to the screening examination
6) Participants who are judged ineligible to participate in the trial by the principal investigator for other reasons, including laboratory test outcomes
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Height
- Secondary Outcome Measures
Name Time Method IGF-1(Insulin-like growth factor-1);IGFBP-3(Insulin-like growth factor binding protein-3);Growth Hormone